ArticleTransplantation and cellular therapy2021

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.

Nelli Bejanyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.